Search hospitals > Pennsylvania > Pittsburgh
Magee Women's Hospital of UPMC
Claim this profilePittsburgh, Pennsylvania 15213
Global Leader in Breast Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Ovarian Cancer
Conducts research for Breast cancer
Conducts research for Cervical Adenocarcinoma
403 reported clinical trials
44 medical researchers
Summary
Magee Women's Hospital of UPMC is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Ovarian Cancer, Breast cancer, Cervical Adenocarcinoma and other specialties. Magee Women's Hospital of UPMC is involved with conducting 403 clinical trials across 569 conditions. There are 44 research doctors associated with this hospital, such as Adam Brufsky, MD, Melissa A. Burgess, Alexander B. Olawaiye, and Adam Olson.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
2Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Adam Brufsky, MDUniversity of Pittsburgh Cancer Institute (UPCI)1 year of reported clinical research
Expert in Breast Cancer
Expert in Breast cancer
31 reported clinical trials
70 drugs studied
Melissa A. BurgessUniversity of Pittsburgh Cancer Institute (UPCI)5 years of reported clinical research
Expert in Soft Tissue Sarcoma
Expert in Cancer
24 reported clinical trials
42 drugs studied
Alexander B. OlawaiyeUniversity of Pittsburgh Cancer Institute (UPCI)2 years of reported clinical research
Expert in Ovarian Cancer
Studies Parotid Gland Cancer
21 reported clinical trials
45 drugs studied
Adam OlsonUPMC-Shadyside Hospital1 year of reported clinical research
Studies Prostatic Neoplasm
Studies Prostate Cancer
17 reported clinical trials
55 drugs studied
Clinical Trials running at Magee Women's Hospital of UPMC
Breast Cancer
Parotid Gland Cancer
Cancer
Prostate Cancer
Breast cancer
Lung Cancer
Ovarian Cancer
Pre-eclampsia
Endometrial Cancer
Testicular cancer
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Contrast-Enhanced Mammography
for Breast Abnormalities
One of the primary criticisms of mammography is that it leads to unneeded stress and anxiety from identification and biopsy of non-cancerous findings. Contrast-enhanced mammography (CEM) has the potential to significantly reduce biopsy rates for commonly seen benign breast lesions while preserving very high cancer detection. The investigators propose a prospective clinical study of patients with diagnostic mammograms rated as BIRADS 4A or 4B and scheduled for a biopsy, in which, prior to undergoing their scheduled biopsy, a CEM procedure is performed. The investigators will test the primary hypothesis that for soft tissue lesions (i.e. masses, asymmetries, architectural distortions) initially rated BI-RADS 4A/4B adding CEM will reduce, by at least 20%, the number of biopsy recommendations for actually benign cases and, at the same time, provide a negative predictive value (NPV) higher than 95%.
Recruiting3 awards Phase 43 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Magee Women's Hospital of UPMC?
Magee Women's Hospital of UPMC is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Ovarian Cancer, Breast cancer, Cervical Adenocarcinoma and other specialties. Magee Women's Hospital of UPMC is involved with conducting 403 clinical trials across 569 conditions. There are 44 research doctors associated with this hospital, such as Adam Brufsky, MD, Melissa A. Burgess, Alexander B. Olawaiye, and Adam Olson.
Where is Magee Women's Hospital of UPMC located?
**Directions to Magee-Womens Hospital of UPMC, Pittsburgh, PA:**
- From the north, start on I-279 S and follow signs for I-579 S/Veterans Bridge.
- Continue onto US-19 Truck S/US-22 E/US-30 E/PA-8 S, and take exit 72B for Oakland Ave.
- Turn left onto Oakland Ave, then right onto Fifth Ave. The hospital will be on your left.
Who should I call to ask about financial aid or insurance network?
**Financial Assistance at Magee Women's Hospital of UPMC:**
- For assistance, contact the Patient Financial Services Center at 1-800-371-8359 or email PatientFinancialServicesCenter@upmc.edu.
- Services include help with governmental assistance, payment plans, reviewing the Financial Assistance program, and support for urgent services for uninsured or underinsured patients.
- Assistance with health insurance applications through the Health Insurance Marketplace is available via UPMC's Certified Application Counselors.
**Insurance Inquiries:**
- Hospital operator: 412-641-1000
- Referral line: 866-696-2433
- UPMC Health Plan bill inquiries: Member Services at 1-888-876-2756 or TTY 711.
**During Your Stay:**
- For questions, please consult your case manager.
What insurance does Magee Women's Hospital of UPMC accept?
Magee Women's Hospital of UPMC accepts insurance plans from Highmark, Blue Cross Blue Shield, Aetna, Cigna, United Healthcare, and UPMC Health Plan. After June 30, 2019, most UPMC doctors and hospitals in the greater Pittsburgh and Erie areas will be out-of-network for Highmark commercial members with specific plans. Highmark or Blue Cross Blue Shield Medicare Advantage plan members will also lose full, in-network access to UPMC after this date.
What awards or recognition has Magee Women's Hospital of UPMC received?
Magee Women's Hospital of UPMC, located in Pittsburgh, Pennsylvania, is renowned for its dedication to women's health, partnering with the Magee-Womens Research Institute and Foundation. It excels in areas such as HIV prevention, ovarian cancer therapies, and women's cancers. The hospital is also celebrated for its environmental efforts, being a member of Practice Greenhealth since 2015, and for its exceptional care, evidenced by three Women's Choice Awards in obstetrics, cancer care, and inpatient experience.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.